Video Transcript:
Good morning, I’m Dr. Breelyn Wilky from the sarcoma program at the University of Colorado Cancer Center.
Cancer Center | 
July 01, 2020
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Research Sarcoma Cancer Bone Cancer
Video Transcript:
Good morning, I’m Dr. Breelyn Wilky from the sarcoma program at the University of Colorado Cancer Center.
Cancer Center | July 01, 2020
Research Prostate Cancer Bone Cancer
When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year survival rate is only 29 percent. Now a University of Colorado Cancer Center study published in the Journal for Immunotherapy of Cancer suggests a new approach, or, possibly two new approaches against these bone metastases: While targeted therapies and anti-cancer immunotherapies have not been especially successful against primary prostate cancers, the study suggests that both these approaches may be effective against the bone metastases that grow from primary prostate cancers, and, in fact, the type of bone metastasis may dictate which targeted therapies and immunotherapies work best.
Cancer Center | December 02, 2019
Cure Today
June 27, 2022
The FDA approved Breyanzi, a CAR-T cell therapy, for the treatment of certain patients with previously treated large B-cell lymphoma.
Radiology Business
June 15, 2022
After training a machine learning model to analyze ultrasound images of the neck, researchers tested their algorithm and have found it correctly flagged 97% of likely cancerous nodules of the thyroid gland.
News Medical
June 14, 2022
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies.
The Scientist
May 31, 2022
A CU Cancer Center researcher recently published a study using DNA from thousands of healthy people to help identify disease-causing mutations by using the principle of natural selection.